Self-Reporting Update

Self-Reporting Update

SLCR has revised the Self-Reporting guidance (attached) to reflect the new regulatory requirements effective 11/28/16 regarding reporting of allegations of abuse or incidents that result in serious bodily injury. The self-reporting timeframes for these two areas has been reduced significantly.  Please make sure these new requirements are implemented and policies and procedures are modified to reflect the changes.

ALERT: ICAPP Voluntarily Recalls Certain Lots of Frozen Strawberries

ICAPP Voluntarily Recalls Certain Lots of Frozen Strawberries

  • Some facilities in Missouri were identified on ICAPP’s Distribution List.  Please check your inventory if you received shipments from ICAPP.

The International Company for Agricultural Production & Processing (ICAPP) is voluntarily recalling certain lots of its frozen strawberries out of an abundance of caution in response to a U.S. Food and Drug Administration (FDA) investigation of an outbreak of Hepatitis A. For more information about this investigation, please visit FDA’s outbreak investigation website at www.fda.gov/Food/RecallsOutbreaksEmergencies/Outbreaks/ucm518775.htm. The recalled products were all distributed for sale to and use in food service establishments nationwide — not for use in food products offered for retail sale to consumers. Nonetheless, ICAPP is issuing this news release publicly to help mitigate any possible risk to the public health and to fully ensure that all recalled products are recovered. Although none of ICAPP’s own testing through an established surveillance program or through third party testing of retained samples has identified the presence of Hepatitis A in any of its products, ICAPP has decided to recall all frozen strawberries that it has imported into the United States since January 1, 2016 out of an abundance of caution. No other ICAPP products, frozen or fresh, are covered by this voluntary recall. ICAPP is conducting this voluntary recall after learning that frozen strawberries that it distributed may be linked to a recent Hepatitis A outbreak in the United States. ICAPP has been engaged with FDA in its investigation of this outbreak and is taking this action in consultation with FDA because Hepatitis A virus was detected in four lots of frozen strawberries that were exported to the U.S. by ICAPP. ICAPP is working closely with all of the U.S. distributors of this product to ensure that this recall is effective. Hepatitis A is a contagious liver disease that results from exposure to the Hepatitis A virus, including from food. It can range from a mild illness lasting a few weeks to a serious illness lasting several months. Illness generally occurs within 15 to 50 days of exposure and includes fatigue, abdominal pain, jaundice, abnormal liver tests, dark urine and pale stool. Hepatitis A vaccination can prevent illness if given within two weeks of exposure to a contaminated food. In rare cases, particularly consumers who have a pre-existing severe illness or are immune compromised, Hepatitis A infection can progress to liver failure. Persons who may have consumed affected product should consult with their health care professional or local health department to determine if a vaccination is appropriate, and consumers with symptoms of Hepatitis A should contact their health care professionals or the local health department immediately. ICAPP is fully committed to producing safe and high quality products; consumer safety is its top priority. ICAPP is conducting a comprehensive review of all of its operations and its suppliers to ensure that the food it produces is safe. ICAPP continues to work closely with federal and state authorities and is conducting this recall in cooperation with FDA. For questions or more information, consumers may contact ICAPP by email at customerservice@icapp.com.eg or by phone, between 9:00 am and 5:00 pm Cairo local time, at (201)-541-1624.

Reminder to Use Forms for Administrator and Director of Nursing Change

Use Forms for Administrator and Director of Nursing Change

  • Please remember the SLCR has developed forms for your convenience to use to notify the Licensure and Certification Unit if a change in Administrator or Director of Nursing has occurred in your facility.
  • The forms are located on LTC Application and Forms web page. The instructions for submission are included on the bottom of each form.

Oral Liquid Docusate Sodium Recall

The FDA and CDC announced the voluntary nationwide recall of oral liquid docusate sodium manufactured by PharmaTech and distributed by Rugby Laboratories.  The agency confirmed the product has been contaminated with Burkholderia cepacia, a bacteria linked to an outbreak in five states.  The bug, with resistance to some antibiotics, is more harmful in immunocompromised individuals.

 

More information can be found here.

Region 6 –Manager

Laura Smith

Laura Smith is the new Section for Long-Term Regulation Region 6 Program Manager. Laura has been with the Section for over 16 years, and has held various positions as a Facility Advisory Nurse. She has served as the interim Region 6 Program Manager in the past and most recently has been the complaint supervisor. Laura may be reached at 573-751-2270 or by email at laura.smith@health.mo.gov.

New State Law Effective August 28, 2016

Senate Bill 732

  • Senate Bill 732 established requirements for long-term care facilities to have policies and procedures that require the facility to give advance notification to emergency medical services personnel prior to the transportation of any at-risk behavioral health patient. An at-risk behavioral health patient is defined as any patient who displays violent, homicidal, or suicidal ideation or behavior.
  • There are other provisions of this law regarding emergency transports of at-risk behavioral patients that are of interest, but do not impose additional requirements on long-term care facilities.
  • Please review the bill and ensure appropriate policies and procedures are developed and implemented by the effective date of the legislation. Please contact Shelly Williamson, Assistant Administrator of the Section, at shelly.williamson@health.mo.gov with any questions regarding these new requirements.